Product Information
VRAYLAR 3 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $50.8757 per EA under NDC 61874013030. Its NADAC has been published 527 times since Jul 20, 2016.
FDA first approved this application on Sep 17, 2015.
Strength
3 mg/1
Manufacturer
Allergan, Inc.NDC
61874013030
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARIPRAZINEApproval Type
New Drug (NDA)
FDA Application
NDA204370FDA Approved
9/17/2015
On Market Since
9/17/2015
Pharmacological Classes
Price Statistics
The NADAC for VRAYLAR 3 MG CAPSULE has been published 527 times since Jul 20, 2016, and over the history we have for it it has risen 56.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $50.8757 per EA |
|---|---|
| All-time high | $50.9560 (May 13, 2026) |
| All-time low | $32.3198 (Aug 17, 2016) |
| 52-week high | $50.9560 |
| 52-week low | $48.5107 |
| Median price | $40.4787 |
| Average price | $41.4295 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 527 |
| Tracking since | Jul 20, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VRAYLAR 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VRAYLAR 3 MG CAPSULE, manufactured by Allergan, Inc., is $50.8757 per EA (NDC 61874013030), effective Aug 19, 2026.
How has the price of VRAYLAR 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VRAYLAR 3 MG CAPSULE has risen 56.9%. It has been tracked across 527 weekly CMS publications since Jul 20, 2016.
What are the highest and lowest recorded NADAC prices for VRAYLAR 3 MG CAPSULE?
Since Jul 20, 2016, the NADAC for VRAYLAR 3 MG CAPSULE has ranged from a low of $32.3198 (Aug 17, 2016) to a high of $50.9560 (May 13, 2026), with a median of $40.4787 per EA.
Are there cheaper alternatives to VRAYLAR 3 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VRAYLAR 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VRAYLAR 3 MG CAPSULE?
VRAYLAR 3 MG CAPSULE (NDC 61874013030) is labeled by Allergan, Inc., and CMS classifies it as a brand product.